Biotech

All Articles

AC Immune views 'spots' potential in Alzheimer's medication information

.After more than two decades of work with neurodegenerative illness, Swiss biotech AC Invulnerable c...

GSK loses ph. 2 HPV vaccination over absence of best-in-class possible

.GSK has actually broken up a phase 2 individual papillomavirus (HPV) vaccination from its pipe afte...

OS Treatments refiles $6M IPO to fund HER2 medicine, preclinical ADCs

.Operating system Therapies will note on the NYSE American sell exchange today via a $6.4 million IP...

ALX's waning CD47 response rate sends out stock spiraling down

.ALX Oncology's phase 2 stomach cancer cells feedback fee has deteriorated. After finding its CD47 b...

Ionis axes eye ailment from aim ats of Roche-partnered prospect after data disappoint

.One More of Ionis Pharmaceuticals' key midphase readouts has fallen short of expectations, urging t...

Biogen's chief executive officer said no dangerous handle 2023. He's ready to be daring

.While Biogen's pharma peers are searching for late-stage possessions with little danger, chief exec...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has actually been actually a biotech in search of a pipeline after it junked its l...

Biogen ignores Denali Alzheimer's collab

.Biogen has actually returned civil rights to an early Alzheimer's condition system to Denali Rehabs...

Takeda faucets brand-new mind of US oncology service-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial management hirings, firings and a...

Vertex, hammered through AATD once more, falls 2 properties on throw out stack

.Tip's attempt to alleviate an unusual hereditary disease has actually hit yet another setback. The ...